↓ Skip to main content

A novel adaptive trial design: randomised evaluation of molecular guided therapy for diffuse large b-cell lymphoma with bortezomib (REMODL-B) with two interim analyses to explore safety and efficacy

Overview of attention for article published in Trials, November 2013
Altmetric Badge

Readers on

mendeley
6 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A novel adaptive trial design: randomised evaluation of molecular guided therapy for diffuse large b-cell lymphoma with bortezomib (REMODL-B) with two interim analyses to explore safety and efficacy
Published in
Trials, November 2013
DOI 10.1186/1745-6215-14-s1-o77
Authors

Tom Maishman, Louise Stanton, Andy Davies, Sharon Barrans, Lisa Worrillow, Christoph Mamot, Matt Care, Tikki Immins, Debbie Hamid, Andrew McMillan, Paul Fields, Andrew Jack, Peter Johnson

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 6 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 6 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 3 50%
Researcher 1 17%
Unknown 2 33%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 1 17%
Mathematics 1 17%
Medicine and Dentistry 1 17%
Unknown 3 50%